Alnylam Pharmaceuticals | 营业费用

Operating Expenses 更改 日
Acadia Pharmaceuticals USD 190.62M 5.48M 2024-03
Agios Pharmaceuticals USD 100.26M 13.12M 2024-03
Alnylam Pharmaceuticals USD 537.77M 18.35M 2024-03
Amgen USD 6.46B 469M 2024-03
Arrowhead Research USD 126.19M 13.9M 2024-03
Avrobio USD 7.94M 782K 2024-03
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Incyte USD 789.54M 36.54M 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
Moderna USD 1.43B 1.37B 2024-03
Neurocrine Biosciences USD 410M 52.4M 2024-03
Novartis USD 8.75B 447M 2024-03
PTC Therapeutics USD 255.67M 183.12M 2024-03
Regeneron Pharmaceuticals USD 2.39B 74.9M 2024-03
Sanofi EUR 8.89B 600M 2024-03
Sarepta Therapeutics USD 378.56M 1.6M 2024-03
Takeda JPY 1.01T 86.16B 2023-12
Ultragenyx Pharmaceutical USD 274.18M 24.74M 2024-03
Vertex Pharmaceuticals USD 1.47B 29M 2024-03
Xencor USD 70.66M 9.04M 2024-03



Alnylam Pharmaceuticals 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.